Posts Tagged: pancreatic cancer

West Becomes 1st in Region to Offer Daraxonrasib, a Breakthrough Therapy for Pancreatic Cancer

Posted by & filed under Uncategorized.

We are proud to announce that West will be the 1st cancer center in the Mid‑South to offer Daraxonrasib, a next‑generation targeted therapy representing one of the most significant advances in pancreatic cancer treatment in years.  Daraxonrasib is designed to interrupt key cancer‑driving pathways associated with some of the most aggressive forms of pancreatic cancer. Early clinical data has shown meaningful improvements in tumor response,… Read more »

Gastrointestinal (Digestive) Cancers

Posted by & filed under Uncategorized.

At West Cancer Center & Research Institute, our comprehensive team of specialists are here to provide you with the latest treatments and personalized care plans. We see on average 1,069 new gastrointestinal cancer patients annually for the most common types including colorectal, esophageal, liver, stomach, and pancreatic cancers. Colorectal cancer is ranked third as the... Read more »

Updates in GI Cancers with Dr. Axel Grothey

Posted by & filed under Uncategorized.

Exciting updates in GI Cancers! Dr. Axel Grothey from West Cancer Center shared groundbreaking insights at the Total Health Spring Oncology Review and Renew Conference. He highlighted major advancements in targeted therapies and precision medicine for GI cancers. Here are the key highlights: Gastro-Esophageal Junction (GEJ) Cancers: Dr. Grothey revealed a new biomarker, Claudin 18.2… Read more »